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Abstract
Peroxynitrite is a potent oxidant and nitrating species proposed as a direct effector of myocardial
damage in numerous cardiac pathologies. Whether peroxynitrite also acts indirectly, by modulating
cell signal transduction in the myocardium, has not been investigated. We therefore examined a
possible role of peroxynitrite on the activation of NF-κ B, a crucial pro-inflammatory transcription
factor, in cultured H9C2 cardiomyocytes. H9C2 cells were stimulated with TNF α or LPS following
a brief (20 min) exposure to peroxynitrite. NF-κB activation (phosphorylation and degradation of its
inhibitor I κ B α , nuclear translocation of NF-κ B p65 and NF-κ B DNA binding) triggered by LPS
or TNF α was abrogated by peroxynitrite. Peroxynitrite also inhibited NF-κ B in 2 human endothelial
cell lines activated with TNF α or IL-1 β . These effects were related to oxidative, but not nitrative
chemistry, being still observed while nitration was suppressed by epicatechin. The mechanism of
NF-κ B inhibition by peroxynitrite was a complete blockade of phosphorylation and activation of
the upstream kinase IKK β , required for canonical, pro-inflammatory NF-κ B activation. At the same
time, peroxynitrite activated phosphorylation of NIK and IKK α , considered as part of an alternative,
non canonical NF-κ B activation pathway. Suppression of IKK β-dependent NF-κ B activation
translated into a marked inhibition of the transcription of NF-κ B dependent genes by peroxynitrite.
Thus, peroxynitrite has a dual effect on NF-κ B, inhibiting canonical IKK β-dependent NF-κ B
activation while activating NIK and IKK α phosphorylation, which suggests its involvement in an
alternative pathway of NF-κ B activation. These findings offer new perspectives in the understanding
of the relationships between redox stress and inflammation.
NF-κB is a crucial transcription factor activating inflammatory and anti-apoptotic genes in
response to immunostimulation. NF-κB is a family of dimeric proteins which include NF-κB1
(p50 and its precursor p105), NF-κB2 (p52 and its precursor p100), p65 (RelA), RelB and c-
Rel, the commonest dimer being formed from a p50 subunit and a p65 subunit. NF-κB is
normally held in the cytoplasm in an inactive form, bound to inhibitory proteins, the IκBs. The
critical step in NF-κB activation relies in its dissociation from the IκB protein, which results
from stimulus-induced phosphorylation of IκB, followed by its polyubiquitination and
degradation by the proteasome. IκBs are phosphorylated by a protein kinase complex, IκB
kinase (IKK), composed of a heterodimer of two catalytic subunits, IKKα and IKKβ, associated
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with a dimer of a regulatory subunit, IKKγ or NEMO, NF-κB Essential Modulator (for review,
see (1,2)). Two distinct pathways of NF-κB activation have been described. In the first one,
termed the canonical pathway, IKKβ is activated by an unknown upstream activator via
regulatory IKKγ, and then phosphorylates IκB. This pathway is responsible for activation of
inflammatory responses and the transcription of genes which protect against apoptosis (3–6).
In addition to inflammatory signals, a number of reports have indicated that canonical NF-κB
activation is also redox sensitive, as it can be activated in a number of different cell types by
oxidants and free radicals (7,8). The second pathway of NF-κB activation, termed the non
canonical pathway, is independent from IKKγ and IKKβ, but is based on NF-κB inducing
kinase (NIK) and IKKα-dependent processing of NF-κB p100 to p52, a pathway crucial for B
cell maturation and lymphoid organ development (9–12). In contrast to the canonical pathway,
it is currently unknown whether this alternate pathway is responsive to redox stress.
Peroxynitrite (PN) is a highly reactive oxidant and nitrating species formed by the reaction of
nitric oxide (NO) with superoxide (O2−) (13). PN generation is favored when the production
of both NO and O2− is enhanced, as may occur during inflammation, circulatory shock and
reperfusion injury (14). In the heart, PN generation occurs during myocardial infarction (15),
heart failure (16) and cardiomyopathy due to anthracyclines (17). In such conditions, it is
unknown whether PN only acts as a direct cytotoxic effector, or may have further, indirect
effects related to the modulation of redox sensitive cell signal transduction pathways such as
NF-κB. It is also noteworthy that cardiomyocytes are not only exposed to PN in these
circumstances, but also to additional inflammatory stimuli such as pro-inflammatory cytokines.
Whether PN may alter the cell response to these stimuli has not been evaluated. The present
study was therefore designed to explore a possible crosstalk between PN and inflammatory
stimuli (TNFα and LPS) at the level of NF-κB signaling in cultured cardiomyocytes and
endothelial cells. Our findings demonstrate that PN blocks IKKβ phosphorylation and
activation, thereby preventing nuclear translocation of NF-κB and inflammatory gene
transcription in response to immune stimulation. In parallel, PN strongly activates the
phosphorylation of NIK and IKKα, whether or not the cells are exposed to immune stimuli.
Thus, PN has a dual effect on NF-κB, being an inhibitor of canonical IKKβ-dependent NF-
κB activation pathway while simultaneously activating the phosphorylation of NIK and
IKKα, suggesting its involvement in an alternative pathway of NF-κB activation.
MATERIAL AND METHODS
Cell culture conditions and reagents
H9C2 cells, a clonal line derived from rat heart (ATCC, Manassas, VA) and human
macrovascular endothelial cells (EAhy 926, a generous donation of Prof. D. Hayoz, Division
of Hypertension, Lausanne University Hospital) were grown (5% CO2, 37 °C) in DMEM
(Gibco BRL, Invitrogen, Basel, Switzerland ) supplemented with 10% FBS, 100 units/ml
penicillin and 0.1 mg/ml streptomycin. The human microvascular endothelial cell line
HMEC-1, a generous gift from Dr F.J. Candal, Center of Disease Control and Prevention,
Atlanta, GA, were cultured (5% CO2, 37 °C) in MCDB 131 medium (GibcoBRL) enriched
with 10% FBS, 50 units/ml penicillin, 50 μg/ml streptomycin, and 0.01 mg/ml epidermal
growth factor (EGF) (Roche; Basel, Switzerland). Cells were cultured to 80 percent confluence
and were serum-starved 24h before the experiments. Unless otherwise specified, all the
reagents used in this study were obtained from Sigma-Aldrich (Fluka, Buchs, Switzerland).
Stimulation with PN, LPS, TNFα and IL-1β
PN (Calbiochem), was synthesized as described previously (18). Stocks of PN were stored in
0.4 M NaOH at −80°C. Prior to experimentation, the concentration of PN was determined from
its absorption at 302 nm (extinction coefficient = 1670 M-1 cm-1) (13). For stimulation with
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PN, cells were washed once and then covered with PBS-glucose buffer (50 mM Na2HPO4, 90
mM NaCl , 5 mM KCl, 0.8 mM MgCl2, 0.2 mM CaCl2, 5 mM glucose, pH 7.4). PN was
delivered as a single bolus at a 1:100 dilution. The final concentration of PN was 10–250 μM
depending on the experimental conditions, in agreement with the concentrations of PN used
in previous studies from our laboratory (19), and from other investigators (20–23). Such
concentrations of PN are physiologically relevant, as it has been estimated that the rate of PN
generation may reach up to 1mM/min in an inflamed organ (lung) in vivo (24). Cells were
exposed to PN for 20 min, after which they were washed and replaced in culture medium for
stimulation with either 1μg/ml LPS (E. Coli O127:B8, Sigma Chemicals), 20 ng/ml TNFα
(Socochim SA, Lausanne, Switzerland) or 1 ng/ml IL-1β (PreproTech, London, UK) for the
indicated times. Control experiments were performed using decomposed PN (DP) in NaOH,
obtained by leaving the PN solution overnight at room temperature, after which PN is
completely d e c o m p o s e d a s d e t e r m i n e d spectrophotometrically (19,25). In some
experiments, hydrogen peroxide instead of PN was used to pretreat the cells before
immunostimulation.
Preparation of cytoplasmic and nuclear extracts
Cells were scraped into hypotonic buffer (HEPES 10 mM, pH 7.9, EDTA 0.1 mM, EGTA 0.1
mM, KCl 10 mM, DTT 1 mM, PMSF 1 mM, Na3VO4 1 mM). After addition of NP-40 (0,625
%), the tubes were centrifuged and supernatants containing the cytoplasmic proteins were
stored at −70°C. Pellets were resuspended in hypertonic buffer (HEPES 20 mM, pH 7.9; NaCl
0.4 M, EDTA 1 mM, EGTA 1 mM, DTT 1 mM, PMSF 1 mM). After centrifugation,
supernatants (nuclear extract) were collected and stored at −70°C. Amount of proteins was
quantified by BCA assay.
SDS Page and Western immunoblotting
30 μg of cytoplasmic or 10 μg of nuclear proteins were separated by SDS-Page, transferred to
nitrocellulose membranes and blocked for 1 h at room temperature in PBS/0.1% Tween/3%
nonfat dry milk. For nuclear extracts, the membrane was incubated with a rabbit anti-NF-κB
RelA/p65 Ab (Santa Cruz Biotechnology, Santa Cruz, CA) and for cytoplasmic extracts, the
membrane was incubated with appropriate dilutions of primary anti-IκBα, anti-phospho-IκBα
(both from Santa Cruz), anti-IKKα, anti-IKKβ, anti-phospho-IKKα/β, anti-phospho-IKKα,
anti-NIK, anti-phospho NIK, anti-NF-κ B RelA/p65, anti-α-tubulin (all from Cell Signaling,
Beverly, MA) or anti-nitrotyrosine antibody (Upstate biotechnology, Lake Placid, NY),
followed by incubation with a 1:5000 dilution of the appropriate horseradish peroxidase-
conjugated secondary antibody (Bio-Rad, Hercules, CA). The immunoblot signal was
visualized using enhanced chemiluminescence (ECL, Amersham Biosciences).
Electromobility shift assay (EMSA)
An NF-κ B oligonucleotide probe (5′-AGTTGAGGGGACTTTCCCAGG-3′) was labeled with
α-32PdCTP using the Klenow enzyme (Roche). 10 μg of nuclear proteins were incubated with
EMSA buffer (20 mM Hepes pH 7.9, 50 mM KCl, 0.5 mM EDTA, NP40 0.1 %, BSA 1 mg/
ml, Glycerol 5%), 170 μg/ml poly dIdC and the probe for 20 min at room temperature. Samples
were resolved on a non-denaturing polyacrylamide gel. Gels were transferred to Whatman 3M
paper, dried under vacuum, and exposed to photographic film at −70°C with intensifying
screens. Densitometric analysis of autoradiographs were performed using a Personal
Densitometer and TotalLab Software.
NF-κB gene reporter gene assay
Cells were transiently transfected with 1 μg of a multimeric NF-κB pGL2 luciferase vector and
0.1 μg of the Renilla pRL-TK vector (kind gifts from Prof. T. Calandra, Department of
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Infectious Diseases, Lausanne University Hospital) using Lipofectamine 2000 (Invitrogen,
Basel, Switzerland). The media was changed 6 h after transfection and the cells were grown
overnignt in fresh complete media. Luciferase activity was determined using a standard kit
(Dual-Luciferase Reporter assay system, Promega Biosciences Inc, San Luis Obispo, CA). The
activity of the NF-κB reporter luciferase was standardized to that of Renilla luciferase.
Immunoprecipitation and IKK kinase assay
Cells were lysed in LB (50 mM HEPES, 150 mM NaCl, 1 mM EDTA, 2 mM MgCl2, 1 mM
Na3VO4, 1 mM PMSF, 0.1% NP-40, 10 μg/ml Leupeptin, 10 μg/ml Aprotinin,1μg/ml
Pepstatin, 0.5 mM DTT, 100 μM NaF). IKK was immunoprecipitated by incubation of 200
μg of protein with an anti-IKKβ antibody overnight at 4°C, followed by addition of Protein A
Sepharose beads CL-4B (Amersham) for 3 h. Precipitates were washed 5x with LB and 3x
with Kinase Buffer (20 mM HEPES pH 7.9, 20 mM β-glycerophosphate, 1 mM MnCl2, 5 mM
MgCl2, 2 mM NaF, 1 mM DTT). The kinase reaction was performed by adding 1 μg of
recombinant GST-IκBα (aminoacids1–54, MTR Scientific, Ijamsville, MD) and 5 μCi
γ-32PATP and incubating 30′ à 30°C. Reactions were stopped by addition of 2xLaemmli
sample buffer. Proteins were separated on a 12% polyacrylamide gel, and gels were fixed, dried
and examined by autoradiography.
RNA isolation and polymerase chain reaction
Cells were stimulated with LPS or TNFα for 2 h and total RNA was isolated by TRIZOL
(Invitrogen). RNA was reverse-transcribed to cDNA and amplified by PCR using the One Step
RT-PCR kit from Qiagen (Qiagen AG, Hombrechtikon, Switzerland) with a Tpersonal
Thermocycler (Biometra, Goettingen, Germany). The sequences of the primer pairs were as
follows: rat iNOS (sense, 5′-CTGCATGGAACAGTATAAGGCAAAC-3′; antisense, 5′-
AGACAGTTTCTGGTCGATGTCATGA-3′); rat TNF a (sense, 5′-
TCTGTCTACTGAACTTCGGGGTGAT-3′; antisense, 5′-
CAGCCTTGTCCCTTGAAGAGAACC-3′); rat GAPDH, used as an internal control (sense,
5′-ACCACAGTCCATGCCATCAC-3′; antisense : 5′-TCCACCACCCTGTTGCTGTA-3′).
PCR products were run by electrophoresis on a 2% agarose gel and stained with ethidium
bromide.
Measurement of cell viability by MTT assay
Cell viability was assessed by the mitochondrial-dependent reduction of 3-(4,5-dimethyl-2-
thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) to formazan. Cells were stimulated
for the indicated periods, and then incubated for 60 minutes with MTT (0.5 mg/ml), followed
by aspiration and solubilisation of the cells in 100μl DMSO, and absorbance was measured at
540 nm.
Immunocytochemistry
Cells plated on glass coverslips were treated with PN (20 min), and then fixed with 10%
paraformaldehyde. Cells were then incubated with polyclonal rabbit anti-nitrotyrosine
(Upstate) at room temperature for 2h. A standard immunostaining protocol was then followed
using Vectastain ABC kit from Vecor Laboratories (Burlinghame, CA).
Statistical analysis
Densitometric analyses of blots are shown as mean±sem of n observations. Statistical analysis
was performed using analysis of variance followed by Bonferroni adjustment, and p<0.05 was
considered statistically significant.
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RESULTS
Peroxynitrite inhibits IκBα phosphorylation and degradation, and NF-κB p65 nuclear
translocation elicited by LPS or TNFa
Phosphorylation of IκBα, which targets IκBα for degradation in the proteasome, allows inactive
cytoplasmic NF-κ B dimers to translocate into the nucleus (1,2). Stimulation of H9C2 cells
with LPS or TNFα (Fig. 1A and B) triggered IκBα phosphorylation that was maximal at 10
min and rapidly declined thereafter, most likely due to its known proteasome-dependent
degradation. Phosphorylation of IκBα was associated with IκB degradation, as evidenced by
the marked reduction of IκB signal 30 min after LPS or TNFα (Fig. 1C and D). At 60 min post-
stimulation, the IκB α signal returned to baseline levels, consistent with Iκ B α resynthesis
triggered by the activation of NF-κB (26). Pretreatment of cells with 250 μM PN for 20 min
before LPS or TNFα prevented Iκ B α to be phosphorylated, an effect associated to a complete
inhibition of IκBα degradation. In contrast to the effects of PN, decomposed peroxynitrite (DP)
did not exert any influence on IκBα (Fig. 1A–D). There were no significant changes in the
expression levels of α-tubulin between the different conditions, indicating equal loading of
proteins (Fig. 1E and F).
Nuclear translocation of NF-κB p65 was evaluated by monitoring the levels of p65 (RelA)
protein in nuclear extracts. Both LPS and TNFα induced RelA/p65 nuclear translocation, that
occurred earlier with TNFα (10 min) than with LPS (30 min) and was maintained up to 1 hour
after stimulation (Fig. 2A and B). In keeping with its effects on IκBα phosphorylation and
degradation, PN (but not DP) abrogated the nuclear translocation of RelA/p65 elicited by LPS
or TNF. The changes in nuclear RelA/p65 were clearly due to its nuclear translocation, but not
to changes in the expression levels of RelA/p65, as shown by RelA immunoblots in cytoplasmic
extracts (Fig. 2C and D).
Peroxynitrite prevents NF-κB DNA binding in H9C2, HMEC-1 and EAhy 926 cells
There was no nuclear NF-κB DNA binding in quiescent H9C2 cells, as shown by bandshift
experiments (Fig. 3). After 30 minutes of stimulation, LPS or TNFα strongly induced NF-κB
DNA binding activity, which was abrogated by PN, but not DP (Fig. 3A and B). Concentration-
response experiments indicated that PN already significantly inhibited DNA binding activity
at a concentration of 10 μM, with almost complete inhibition obtained at 100 μM (Fig. 3C and
D). To evaluate possible cell specificity of this effect of PN, NF-κB DNA binding was
determined in two human endothelial cell lines, HMEC-1 and Eahy 926 stimulated with
TNFα, IL-1β, or both. In HMEC-1 cells, NF-κB was activated by TNFα and IL-1β, and this
was eliminated by PN (250μM), but not DP (Fig. 3E). Eahy 926 cells were found to be
responsive to TNFα, but not IL-1β. NF-κB DNA binding elicited by TNFα was again markedly
inhibited by PN pretreatment (Fig. 3F). Thus, the inhibitory effects of PN on NF-κB activation
is observed independently from the stimulus (LPS, TNFα, IL-1β) or the cell type studied.
Peroxynitrite-dependent NF-κB inhibition depends on oxidation, but not nitration
The chemistry of PN encompasses both oxidation reactions and nitration of protein tyrosine
residues (27). Distinction between these two kinds of reactions can be obtained with
epicatechin, which acts as a potent inhibitor of tyrosine nitration elicited by PN (21).
Stimulation with 250 μM PN for 15 minutes induced a widespread nitration of cellular proteins
in H9C2 cells, as evidenced both by western blotting and by immunocytochemical detection
(Fig. 4A and B). Nitration was concentration-dependently inhibited by epicatechin, in
accordance with previous data by other investigators (21), with complete inhibition obtained
at 100 μM and above. We thus used a concentration of 100 μM epicatechin to evaluate the role
of nitration on NF-κB inhibition by PN. As shown in Fig. 4C, the PN-dependent prevention of
IκBα phosphorylation in response to LPS was not affected by epicatechin, indicating that PN
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does not block NF-κB activation via nitration reactions and supporting that an oxidative type
of chemistry is responsible for this effect. To further confirm that the inhibition of NF-κB by
PN was due to oxidation, we assessed the possible effect of another oxidant species, hydrogen
peroxide (H2O2), on the process of NF-κB activation by LPS in H9C2 cells. As shown in Fig.
4D and E, H2O2 prevented the DNA binding activity of NF-κB as did PN. However, in contrast
to PN, the concentrations of H2O2 required for this inhibition were higher (100 μM and above).
Also, the effect of H2O2 could be fully reversed in the presence of catalase, whereas the latter
did not affect the inhibition of NF-κB activation by PN (Fig. 4F and G). Finally, the PN-
mediated inhibition of NF-κB-DNA binding triggered by LPS was completely prevented when
cells were pretreated for 2h with 250μM of the superoxide dismutase (SOD) mimetics and
antioxidant agent Mn(III)-tetrakis-(4-benzoic acid) porphyrin (MnTBAP) (Fig. 4H). Overall,
these data indicate that PN-dependent inhibition of NF-κB occurs as a result of oxidative, but
not nitrative processes.
Peroxynitrite inhibits IKKβ phosphorylation and IKK kinase activity, but activates the
phosphorylation of NIK and IKKα
Activation of IKK represents the crucial step in the process of NF-κB activation (1). As shown
in Fig. 5A and B, both LPS and TNFα enhanced IKK activity, as demonstrated by kinase assay
experiments. Following LPS, IKK activation started at 10 min, reached a peak at 15–20 min
and then steadily declined until 60 min. Upon stimulation with TNFα, the pattern was similar,
although IKK activity was induced earlier than with LPS, starting as early as 5 min after
TNFα, peaking at 5 to10 min and disappearing thereafter. IKK activation was associated with
an enhanced phosphorylation of both IKKα and IKKβ by LPS and TNFα, which was maximal
at 20 min after LPS and 10 min after TNFα (Fig. 5A an B).
Due to the inhibition of NF-κB activation by PN, we assessed whether this effect could be
related to the inhibition of IKK activation. The possible influence of PN was explored in cells
stimulated with LPS for 20 min, or with TNFα for 10 min, as these time points corresponded
to the peak activation of IKK by these stimuli. Fig. 5C (LPS) and 5 D (TNFα), unequivocally
demonstrate that PN completely prevented the activation of IKK triggered by the two
inflammatory stimuli.
Since IKK activation relies on the phosphorylation of two serine residues within the activation
loops of IKKα and IKKβ(1), we examined the effects of PN on IKK phosphorylation. Both
LPS (Fig. 5E) and TNFα (Fig. 5F) triggered the phosphorylation of IKKα and IKKβ after 20,
respectively 10 min. When cells were pretreated with PN for 20 min, the phosphorylation of
IKKβ was totally prevented, while PN did not exert any inhibition on the phosphorylation of
IKKα (Fig. 5E and F, densitometric analysis, Fig. 5G and H). The effects of PN were not
associated with significant changes in the expression levels of IKKα, IKKβ and α-tubulin.
Thus, PN prevents IKK activation by impairing specifically the phosphorylation of IKKβ.
We then sought to determine whether PN on its own has the ability to phoshorylate IKKα. As
shown in figure 6A and B, The phosphorylation of IKKα in cells treated with LPS or TNFα
was maintained for up to 2h only if they were pretreated with PN. Furthermore, PN alone,
independently from any stimulation with LPS or TNFα, activated the phosphorylation of
IKKα, an effect evident already after 10 min and further increasing at 15 and 20 min (Fig. 6C).
Previous studies have shown that IKKα phosphorylation relies on the upstream activation of
NIK (12,28), and we thus determined whether PN might activate this particular signaling
cascade. As indicated in Fig. 6C, PN induced the phosphorylation of NIK, with a time-course
parallel to that of IKKα phosphorylation.
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Peroxynitrite inhibits the transcription of NF-κB-dependent genes
In order to evaluate whether PN-dependent NF-κB inhibition might influence NF-κB-
dependent gene transcription, we first addressed the influence of PN on NF-κB-luciferase
reporter gene expression determined 4 hours after TNFα stimulation. While PN alone had no
effect, TNFα induced more than a 20-fold increase in the expression of the transfected NF-
κB-dependent luciferase gene (Fig. 7A). This increase was not modified by pretreatment of
cells with DP, whereas PN induced an almost complete inhibition of luciferase expression. We
then evaluated the concentration-dependence of this effect by pretreating cells with increasing
concentrations (10–250 μM) of PN and then TNFα or LPS for 4h. Fig. 7B and C show that PN
at all concentrations significantly inhibited the TNFα and LPS-dependent luciferase
expression. To make sure that these effects were not related to nonspecific cytotoxicity by PN,
we assessed cell viability (MTT assay) in H9C2 cells 4 hours after a 20 min exposure to 250
μM PN. As shown in Fig. 7D, PN only marginally affected cell viability, which indicates that
the decrease in luciferase expression was indeed consecutive to NF-κB inhibition but not to
cell death.
We also explored whether endogenous genes, which are known to be transcriptionnally
regulated by NF-κB, would be affected by PN. Both LPS and TNFα induced the transcription
of the genes encoding inducible NO synthase (iNOS) (Fig. 8A and B) and TNFα (Fig. 8C and
D), and this was not influenced when the cells were pretreated with DP. In contrast, PN
completely abrogated the transcription of iNOS and TNFα in cells stimulated either with LPS
or TNFα.
DISCUSSION
Recent studies have indicated that PN is generated in large amounts in the myocardium during
myocardial reperfusion injury (15), chronic heart failure (16), circulatory shock (29) and
anthracycline cardiomyopathy (17). While PN has generally been considered as directly
biotoxic towards cardiomyocytes, we now provide the novel evidence that PN also behaves as
an important modulator of cell signal transduction at the level of NF-κB. A short exposure to
PN exerted a marked inhibition towards IκBα phosphorylation and degradation, p65 nuclear
accumulation and NF-κB DNA binding triggered by LPS or TNFα in H9C2 cardiomyocytes
(Fig.1–3). This inhibition was already significant at low concentrations of PN (10 μM), with
more than 80% inhibition obtained at 50 μM of the oxidant. Similarly, PN inhibited NF-κB
activation in 2 additional cell lines, HMEC-1 and EAhy 926 endothelial cells, stimulated with
TNFα and IL-1β (Fig. 3E and F), which indicates that the inhibitory effect of PN on NF-κB is
independent of type of cell and stimulus.
PN has been associated with two different types of chemistry, namely oxidation reactions and
nitration of tyrosine residues. Our finding that epicatechin, which fully reversed the nitration
induced by PN, did not affect the inhibition of NF-κB activation (Fig. 4A–C), indicates that
oxidation rather than nitration was the relevant chemical reaction underlying this effect of PN.
This conclusion is further supported by the findings that (a) another strong oxidant species,
hydrogen peroxide, also inhibited NF-κB activation in H9C2 cells stimulated with LPS,
although this effect was observed at concentrations higher than those of PN (Fig. 4D and E),
and (b) the inhibition of NF-κB-DNA binding activity by PN was totally prevented by the SOD
mimetics and antioxidant compound MnTBAP (Fig. 4H). These observations argue against
the concept that NF-κB is a general sensor of cellular redox stress. Such redox sensitivity of
NF-κB has been proposed on the basis that anti-oxidants can prevent NF-κB activation in
response to cytokines and that NF-κB can be activated upon the direct exposure of cells to
reactive oxygen species (7,30), but this issue is currently debated for a number of reasons. First,
NF-κB can be activated by oxidant stress only in some, but not all cell types (8). Second, there
are multiple mechanisms accounting for NF-κB activation in response to redox stress (8).
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Oxidants have been shown to activate NF-κB either via IKK-dependent IκBα serine
phosphorylation (31), or via tyrosine phosphorylation of IκBα at Tyr 42 (32). It has been
claimed that this variability in the modes of action of oxidants does not support their role as
universal NF-κ B activators (8). Third, it has been demonstrated that endogenously produced
reactive oxygen species do not mediate NF-κB activation in Hela, HT-29, L-929 and Jurkat T-
cells (33). Fourth, a recent report indicated that oxidant stress inhibited NF-κB activation by
TNFα in alveolar RLE and C10 cells (34). Our data further challenge the issue of the redox
responsiveness of NF-κB, by providing strong experimental evidence that a short episode of
redox stress with PN potently inactivates consecutive activation of NF-κB by pro-inflammatory
signals. Since PN is generated in many different pathological conditions, these findings may
have important consequences to understand the ramification between PN formation and the
regulation of inflammatory processes in vivo.
The key regulatory step in NF-κB activation is the activation of the upstream kinase IKK (1).
The activation of IKK subunits relies in the phosphorylation of serine residues within their
activation loops (Ser176 and 180 for IKKα and Ser177 and 181 for IKKβ) (35). Here, we
provide the first experimental evidence that PN prevents LPS and TNFα-dependent NF-κB
activation through a complete blockade of IKK activity, due to inhibition of IKKβ
phosphorylation (Fig. 5). These findings are consistent with previous data from the literature
indicating that IKKβ represents a key target of various NF-κB inhibitors, including
cyclopentone prostaglandins (36), arsenite (37) and NO (whose chemical reactivity is distinct
from that of PN (14)).
Another striking observation of the present study was the opposite influence of PN towards
the α and β subunits of IKK. Whereas PN blocked LPS and TNFα-dependent IKKβ
phosphorylation, it did not reduce, but instead promoted IKKα phosphorylation (Fig. 5 and 6).
Such a contrasted influence of a single compound on IKKα and β has not been previously
reported, but is consistent with the fact that phosphorylation of IKKα and IKKβ proceeds
through distinct mechanisms. Whereas IKKβ phosphorylation critically depends on the
regulatory subunit IKKγ, IKKα can be directly phosphorylated by the upstream kinase NIK
(1). Recent reports indicate that NIK/IKKα mediate an alternative, non canonical NF-κB
pathway, in lymphoid cells in response to certain stimuli including LTβR, BAFF and CD40,
resulting into the processing of the NF-κB subunit p100 into p52 (9–11,38). Our finding that
phosphorylation of IKKα by PN was associated with the simultaneous phosphorylation of NIK
(Fig. 6C), suggests that redox stress mediated by PN may activate a similar pathway in
cardiomyocytes. However, we did not find evidence of p100 processing into p52 in cells
stimulated with PN (data not shown), implying that the downstream events triggered by PN-
mediated phosphorylation of NIK and IKKα remain yet to be established.
Beside its function in non canonical NF-κB activation, a novel role of IKKα in the canonical
pathway of NF-κB activation has been recently identified by Lawrence and coworkers (39).
In this study, mice expressing an inactivatable variant IKKα (ikkαAA/AA) showed a markedly
increased inflammatory response following LPS administration, characterized by an increased
expression of NF-κB-target genes in tissues (lung and liver). Furthermore, LPS-stimulated
ikkα AA/AA macrophages disclosed a markedly prolonged NF-κB-DNA binding activity relative
to wild-type cells, related to a reduced degradation of the NF-κB subunits RelA (p65) and c-
Rel in ikkαAA/AA macrophages (39). Overall, the results of this study clearly identified a
previously unrecognized function of IKKα as a negative regulator of NF-κB activation,
indispensable for the resolution of inflammation. Thus, IKKα and IKKβ play opposite (down-
versus upregulation), yet complimentary roles in inflammation. Our results that PN-mediated
inhibition of NF-κB activation is associated with an opposite regulation of IKKα (activation)
and IKKβ (inhibition) is therefore consistent with the distinct functions of these subunits
reported in the study by Lawrence et al.
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In keeping with the findings that PN blocked IKKβ-dependent NF-κB activation, we found
that it also markedly reduced the transcription of NF-κB dependent genes in cardiomyocytes.
Using a luciferase reporter assay, we found a marked reduction of luciferase activity in cells
stimulated with TNFα or LPS after PN pretreatment (Fig. 7A–C). Also, PN completely blocked
the transcription of the endogenous inflammatory genes encoding iNOS and TNFα (Fig. 8).
Importantly, both TNFα and NO generated from iNOS have been proposed as potential
myocardial depressant effectors in pathologies such as septic shock (40) and chronic heart
failure (41), where enhanced myocardial formation of PN has also been documented. Our data
therefore suggest that PN generation in vivo might unexpectedly down-regulate the expression
of pro-inflammatory mediators and cardiodepressant molecules, providing a counterregulatory
mechanism to prevent overt inflammation and myocardial failure in various pathological
conditions.
In summary, our data show that PN, acting through oxidative but not nitrative chemistry, is a
potent inhibitor of canonical NF-κB activation triggered by inflammatory cytokines or LPS,
as proposed in the diagrammatic scheme presented in figure 9. This effect is related to the
blockade of IKKβ phosphorylation, resulting in the inactivation of the kinase and downstream
signaling. The inhibition of IKKβ dependent NF-κ B activation by PN translates into a complete
inhibition of the transcription of NF-κB dependent genes. Furthermore, PN simultaneously
activates NIK and IKKα phosphorylation, suggesting its potential role in an alternative pathway
of NF-κB activation, whose cellular consequences remain to be clarified. These findings offer
new perspectives in understanding the relationships between oxidant stress and inflammation.
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Fig. 1.
Peroxynitrite inhibits IκBα phosphorylation and degradation triggered by inflammatory stimuli
in H9C2 cells. H9C2 cells were either not stimulated (NS) or stimulated with LPS (1μg/ml, A,
C, E) or TNFα (20 ng/ml, B, D, F) after pretreatment with either decomposed peroxynitrite
(DP) or authentic peroxynitrite (PN, 250 μM) for 20 min. Both LPS and TNFα induced IκBα
phosphorylation (A, B) and degradation (C, D), which were prevented by PN but not DP.
Expression levels of α-tubulin (E, F) are shown as loading controls.
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Fig. 2.
Peroxynitrite prevents the nuclear translocation of the p65 (RelA) subunit of NF-κB induced
by LPS or TNFα. H9C2 cells were left unstimulated (NS) or were stimulated with LPS (1μg/
ml, A, C) or TNFα (20 ng/ml, B, D) after a 20 min pretreatment with 250 μM peroxynitrite
(PN) or decomposed peroxynitrite (DP) for 20 min. Nuclear RelA accumulation was markedly
increased following LPS or TNFα (A, B), with no changes in the levels of cytoplasmic RelA
(C, D). PN, but not DP, prevented RelA nuclear translocation.
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Fig. 3.
Peroxynitrite inhibits NF-κB DNA binding activity triggered by inflammatory stimuli in H9C2,
HMEC-1 and EAhy 926 cells. H9C2 cells were not stimulated (NS) or treated with LPS (1μg/
ml, A) or TNFα (20 ng/ml, B). Both LPS and TNF triggered NF-κB DNA binding, an effect
suppressed by pretreatment with peroxynitrite (PN, 250 μM, 20 min), but not decomposed PN
(DP). The inhibitory effect of PN on LPS-mediated NF-κB DNA binding was concentration-
dependent (C, D). PN, but not DP, also inhibited NF-κB DNA binding in HMEC-1 cells (E)
and EAhy 926 cells (F) stimulated with TNFα (20 ng/ml), IL1β (1 ng/ml) or both. Bar graph
shows mean±sem of at least 4 observations. * p<0.05 (ANOVA followed by Bonferroni
adjustments)
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Fig. 4.
Peroxynitrite inhibits NF-κB independently from nitration reactions. Treatment of H9C2 cells
for 20 min with 250 μM peroxynitrite (PN) induced nitration of cellular proteins, as indicated
by the formation of 3-nitrotyrosine, which was abrogated by pretreatment with epicatechin
(EC) at concentrations of 100 μM and above (A, western, B, immunochemistry). Although 100
μM EC efficiently prevented tyrosine nitration, it did not influence the PN dependent inhibition
of NF-κB activation in cells stimulated with LPS, as assessed by IκBα phosphorylation (C).
Expression levels of α-tubulin are shown as a loading control. Hydrogen peroxide (H2O2),
another oxidant species, was also able to inhibit NF-κB, as shown by band shift experiments,
although this effect required higher concentrations than PN (D, E). The inhibitory effect of
H2O2 on NF-κB DNA binding was reversed in the presence of 100–10000 Units catalase
(CAT), whereas the effect of PN was not influenced by catalase (F, G). Finally, the prevention
of NF-κB-DNA binding activation produced by PN was reversed after 2h pretreatment with
250 μM of the SOD mimetics and antioxidant MnTBAP (H). NS: Not Stimulated. MnT:
MnTBAP.
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Fig. 5.
Peroxynitrite inhibits IKK kinase activity by preventing specifically the phosphorylation of
IKKβ in H9C2 cells. A and B: IKKkinase assay (KA) in cells treated with LPS or TNFα. LPS
strongly activated IKK kinase from 10 to 30 minutes (A), whereas the effects of TNFα were
most pronounced at 5 and 10 minutes (B). The activation of IKK was associated with an
increased phosphorylation of IKKα and IKKβ by LPS and TNFα. IKKα levels are shown as
an internal control. C and D: IKK kinase activity in cells pretreated with peroxynitrite (PN,
250 μM, 20 min) and stimulated with LPS (C, 20 min) or TNFα (D, 10 min). PN abrogated
IKK activity triggered by LPS or TNFα. E and F: Phosphorylation of IKKα and β was induced
both by LPS (20 min, E) and TNFα (10 min, F). PN completely prevented the phosphorylation
of IKKβ triggered by LPS and TNFα, whereas it did not reduce IKKα phosphorylation in
response to LPS and TNFα. No significant changes in the levels of IKKα, IKKβ and α-tubulin
were found between the different conditions. G and H: densitometric analysis of phospho-IKK
western blots showing mean±sem of 3 observations. NS: Not Stimulated. * p<0.05, ANOVA
followed by Bonferroni adjustment.
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Fig. 6.
PN activates the phosphorylation of IKKα and NIK. IKKα phosphorylation was monitored in
cells stimulated with LPS (A) or TNFα (B) for 10 to 120 min, in the absence or presence of
peroxynitrite (PN). In the presence of PN, there was a strong phosphorylation of IKKα,
maintained for up to 120 min after LPS or TNFα, with no change in total IKKα. C: PN alone
strongly activated the phosphorylation of IKKα and NIK, an effect starting after 10 min. NS:
Not Stimulated. NSB: non specific band
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Fig. 7.
PN inhibits the activity of a NF-κB-luciferase gene reporter activated by LPS or TNFα. Cells
were either not stimulated (NS), or stimulated with peroxynitrite alone (PN, 250μM, 20 min),
or TNFα (20 ng/ml) following pretreatment for 20 min with decomposed peroxynitrite (DP)
or PN. Luciferase activity was measured after 4 h (A). PN alone had no effect, while TNFα
induced a 20-fold increase in luciferase activity, an effect unchanged by DP, but significantly
prevented by PN. B and C: PN-dependent inhibition of luciferase activity triggered by TNFα
(B) or LPS (C) is concentration–dependent. D. The effects of PN are not related to non specific
cytotoxicity. Cells were treated with PN (250 μM, 20 min) or DP (20 min). Cell viability was
assessed 4 h later by the MTT assay. PN only marginally affected cell survival (86% viability
at 4h). Bar graphs are means ± sem of at least 4 measurements. * p< 0.05 vs TNF or LPS alone
(ANOVA followed by Bonferroni adjustments)
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Fig. 8.
PN inhibits the transcription of endogenous NF-κB-dependent genes. The transcription of
inducible nitric oxide synthase (iNOS) and TNFα mRNA was evaluated in response to LPS
(A, C) or TNFα (B, D) stimulation for 2h. LPS and TNF induced iNOS and TNFα gene
transcription, an effect abrogated by pretreatment with peroxynitrite (PN, 250 μM, 20 min),
but not decomposed PN (DP, 20 min). NS: Not Stimulated.
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Fig. 9.
A model for peroxynitrite-mediated interference with the NF-κB pathway. Immune stimuli
activate the canonical NF-κB pathway, by inducing phosphorylation and activation of IKKβ,
in a process regulated by IKKγ. In turn, IKKβ phosphorylates IκBα, leading to its proteasomal
degradation. NF-κB dimers (mostly p50/p65) then translocate into the nucleus, bind to κB
consensus sequences, and activate the transcription of target genes. In the presence of
peroxynitrite, IKKβ phosphorylation is impaired, thereby blocking IKKβ activation and
downstream signaling (as indicated by the (−) signs). At the same time, peroxynitrite activates
the phosphorylation of IKKα, most probably via the phosphorylation and activation of the
upstream kinase NIK. The cellular targets of IKKα in this model remain to be defined.
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Fig. 10.
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